Form 8-K - Current report:
SEC Accession No. 0001104659-25-052250
Filing Date
2025-05-23
Accepted
2025-05-23 09:20:20
Documents
12
Period of Report
2025-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2516044d1_8k.htm   iXBRL 8-K 42711
  Complete submission text file 0001104659-25-052250.txt   211376

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zura-20250521.xsd EX-101.SCH 3011
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE zura-20250521_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zura-20250521_pre.xml EX-101.PRE 22356
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2516044d1_8k_htm.xml XML 3804
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40598 | Film No.: 25979560
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)